other laboratories. Children show considerably higher lymphocyte counts but extensive data on normal children for these tests are not available.
Lymphoid Cells other than Tand B Cells A small proportion of peripheral blood mononuclear cells neither form sheep cell rosettes nor have surface immunoglobulin. These include monocytes and K cells. K cells are cytotoxic lymphocytes which are not immunologically competent and which develop independently of thymic influence. They are able to kill cells whose antigens are sensitized with IgG, being triggered to cytotoxic activity by the Fc part of the IgG molecule. K cell activity can be quantitated by assessing the number of lymphocytes which have to be added to a standard preparation of antibodysensitized target cells to produce a given level of killing in a given time. The percentage cells killed increases with the logarithm of the number of K cells.
Phytohamagglutinin-induced Cytotoxicity
In the presence of phytohaemagglutinin (PHA) human peripheral blood lymphocytes will kill certain target cells, and this cytotoxic activity can be assayed in a similar way to that of K cells.
The active cytotoxic cells in the presence of PHA are distinct from K cells. They can be found among lymphocytes which have been experimentally depleted of cells bearing demonstratable surface immunoglobulin or receptors for the Fc part of immunoglobulin G. It may be that this indiscriminate cytotoxic activity is induced in the cytotoxic T cells described above.
Mitogens
Certain lymphocytes can be induced to divide by a variety of agents including bean extracts such as concanavalin A and phytohimagglutinin; filtrate of staphyloccoci and poke-weed extract. Probably none of these agents is an entirely specific mitogen for a single lymphocyte type and the nature of cells responding to some extent depends on culture conditions. Of the common mitogens concanavalin A and phytohmmagglutinin in soluble form are predominently T cell mitogens, while poke-weed mitogen stimulates both T and B cell to divide. Despite the doubts about the specificity of these agents abnormal responses are characteristic of certain conditions and as such they are useful tests for clinical evaluation.
Other Cell Markers
A number of markers are not specific for one cell type. The most important of these are receptors for the Fc part of IgG and the third component Table 2 lists the characteristics of commonly used functional and marker assays in relation to human lymphocytes.
In practice certain of the differences between cell types indicated in Table 2 may be quantitative rather than absolute. Consequently the properties listed are only shown as positive if they are easily and unequivocally demonstratable.
The Role ofLymphocyte Population Assays These assays are now being used at the research level in many aspects of human disease. They are already of value in the diagnosis of immunodeficiency diseases. But the changes recorded in many other disorders as well as alterations associated with therapy make it inevitable that assessment of lymphocyte populations in man is going to be widely used in medicine in the future. Killer (K) cells belong to a subpopulation of lymphoid cells or monocytes which in vitro are able to destroy target cells, such as chicken red blood cells coated with antigen-antibody complex. Lymphoid-cell-mediated antibody-dependent (LDA) cytotoxicity has been recognized for some years (Moller 1965 , Perlmann & Holm 1969 
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MacLennan & Loewi 1968) but its precise biological significance remains uncertain. Ringertz et al. (1971) and Fahkri & Hobbs (1972) have, however, suggested that this highly efficient cytotoxic mechanism could be involved in vivo in the production of autoallergic tissue damage.
Subsequent experiments (Calder, Penhale et al. 1973 , Calder 1974 (Fig 1) Moller & Svehag 1972 , Perlmann et al. 1973 ). If, therefore, antigen-antibody complexes are present in the serum of patients with Hashimoto thyroiditis it should be possible to specifically activate K cells by incubation in serum known to contain 19s localized cytotoxic activity. Experiments of Calder, McLeman & Irvine (1973) have shown that the incubation of peripheral blood lymphoid cells with Hashimoto serum followed by thorough washing to eliminate the possible transfer of antibody, renders them cytotoxic to target cells coated with thyroglobulin. Since lymphocytes have low affinity for antibody unreactive with antigen (Coombs & Franks 1969) , this data provides further indirect evidence for the presence of antigen-antibody complexes in the serum of patients with Hashimoto thyroiditis. This cytotoxic mechanism may prove to be of significance in the pathogenesis of autoimmune thyroid disease, since in vivo a high proportion of circulating lymphoid cells could thus be specifically recruited to destroy target cells in the thyroid gland.
human peripheral blood lymphoid cells from normal donors were cytotoxic to thyroglobulincoated target cells which had been preincubated with heat-inactivated serum from patients with Hashimoto thyroiditis, primary hypothyroidism and thyrotoxicosis. Cytotoxicity characteristically required both lymphoid cells and antibody, cells or antibody alone being ineffective in causing target cell damage. Cytotoxicity was also found to correlate with the titre of thyroglobulin tanned cell hiamagglutinating antibody. One might postulate that in vivo a similar cytotoxic mechanism occurs whereby the coating of thyroid epithelial cells with small quantities of autoantibody renders them susceptible to damage by K cells.
Further studies on the identification and localization of the cytotoxic activity in Hashimoto serum showed that it was an antibody of the IgG class, detectable in both the 19s and 7s Sephadex G200 separation profile (Calder, Penhale et al. 1973) . It was suggested that the K-cell-dependent cytotoxic activity demonstrable in the higher molecular weight region of whole serum was due to the presence of antigen-antibody complexes. That it could be due to aggregated IgG was Another method currently available for the in vitro detection of soluble immune complexes is an anticomplementary assay described by Mowbray et al. (1973) . This test is based on the binding of C'l to circulating immune complexes after heat inactivation of the C'1 found in the blood with a subsequent back titration of added guinea-pig complement and has been used successfully to detect immune complexes in patients with dermatitis herpetiformis (Mowbray et al. 1973) . Results of Calder, Penhale, Barnes & Irvine (1974) using this method have shown that sera from a significant proportion of patients with Hashimoto thyroiditis, primary hypothyroidism and thyrotoxicosis contained anticomplementary activity when compared with age and sex matched control sera. The observed anticomplementary activity was found to be localized predominantly in the ascending peak of the IgG distribution profile, suggesting that this property may be due to an IgG antibody attached to a small antigenic determinant. This could be in the form of thyroglobulin antibody combined with small fragments of thyroglobulin (although thyroglobulin antibodies are only weakly complement fixing) or alternatively in the form of complexes with other antigens; in particular, the complement-fixing antibodies reacting with thyroid microsomal antigens.
An alternative in vitro test for the presence of soluble immune complexes is the inhibition of K cell cytotoxicity as described by Jewell & MacLennan (1973) which has been used to detect complexes in patients with ulcerative colitis or Crohn's disease. Soluble immune complexes inhibit LDA cytotoxicity by competing for the Fc receptor on the effector cytotoxic K cell. Current experiments of Calder, Penhale & Irvine (1974) using this technique have shown that serum from patients with Hashimoto thyroiditis, when compared with serum from age and sex matched control subjects, causes a significant inhibition of LDA cytotoxicity. This data would again suggest that patients with Hashimoto thyroiditis possess circulating soluble immune complexes. As with the anticomplementary assay, however, this test gives no indication of the exact chemical nature of the immune complex and one can only hypothesize as to the nature of the antigenic component involved.
To summarize: evidence exists that in vitro K cells have a high cytotoxic potential. It is possible that in vivo these cells are actively involved in the production of thyroid cell damage in patients with autoinmune thyroid disease in one or other of two ways. First, in the target organ the coating of tissue with autoantibody will render them susceptible to K-cell-mediated lysis. Alternatively, the presence of immune complexes in antibody excess in thecirculation could activate quiescent K cells, giving them the specificity to destroy thyroid target cells. 
Long-acting Thyroid Stimulator and Related Factors
There is much circumstantial evidence that Graves' disease is an autoimmune disorder and that the hyperthyroidism may result from stimulation by thyroid-specific antibodies. This paper deals with two abnormal immunoglobulins, associated with the disease, which are ofparticular interest in this context: the long-acting thyroid stimulator (LATS), and the more recently discovered LATS protector, which may be a human-specific thyroid stimulator.
Long-acting Thyroid Stimulator LATS is an IgG, which can be shown to stimulate the thyroid in man and experimental animals, the activity being associated with the Fab fragment and with the heavy chain. The LATS binds to a 4S protein, probably located in the plasma membrane in human thyroid homogenates and this binding can be reversed by acid elution or by treatment with thiocyanate, with recovery of the LATS activity.
LATS is usually detected by bioassay using its capacity to stimulate release of 1811 from prelabelled mouse thyroid glands as the index of activity. Although chemically and immunologically quite distinct, the actions of thyroidstimulating hormone and LATS on the thyroid are very similar and both are mediated by cyclic adenosine monophosphate; the only real difference appears to be the longer time course of action of LATS and this can be demonstrated in both in vivo and in vitro systems.
For these reasons it was postulated that LATS is an autoantibody which interacts with and stimulates the human thyroid, so causing the hyperthyroidism of Graves' disease. However, it can only be detected in some, not all, patients with the disease so it is unlikely that LATS is the sole cause of the hyperthyroidism. 
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